Yu Fan

Dr. Yu Fan

orcid
Researching kidney metabolism, phosphate homeostasis, and ch...

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Theranostics
Verified
Journal Article
Open access
JWJiao Wang
Jiao Wang
MXMingrui Xiong
Mingrui Xiong
Yu FanYu Fan
Yu Fan
CLChengyu Liu
Chengyu Liu
QWQing Wang
Qing Wang
KHKun Huang
Kun Huang
Rationale: Ischemia-reperfusion (IR) induced acute kidney injury (AKI) causes serious clinical problems associated with high morbidity and mortality. Mecp2 is a methyl-CpG binding protein, its mutation or deletion causes a neurodevelopment disease called Rett syndrome. Notably, some Rett syndrome patients present urological dysfunctions. It remains unclear whether and how Mecp2 affects AKI.

17 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
CYChen Yang
Chen Yang
HXHuidie Xu
Huidie Xu
DYDong Yang
Dong Yang
YXYunhao Xie
Yunhao Xie
MXMingrui Xiong
Mingrui Xiong
LZLing Zheng
Ling Zheng
Acute kidney injury (AKI) exhibits high morbidity and mortality. Kidney injury molecule-1 (KIM1) is dramatically upregulated in renal tubules upon injury, and acts as a biomarker for various renal diseases. However, the exact role and underlying mechanism of KIM1 in the progression of AKI remain elusive. Herein, we report that renal tubular specific knockout ofKim1attenuates cisplatin- or ischemia/reperfusion-induced AKI in male mice. Mechanistically, transcription factor Yin Yang 1 (YY1), which is downregulated upon AKI, binds to the promoter ofKIM1and represses its expression. Injury-induced KIM1 binds to the ECD domain of death receptor 5 (DR5), which activates DR5 and the following caspase cascade by promoting its multimerization, thus induces renal cell apoptosis and exacerbates AKI. Blocking the KIM1-DR5 interaction with rationally designed peptides exhibit reno-protective effects against AKI. Here, we reveal a YY1-KIM1-DR5 axis in the progression of AKI, which warrants future exploration as therapeutic targets.

1 January 2023 in Theranostics
Verified
Journal Article
Open access
PDF file
Yu FanYu Fan
Yu Fan
YYYangmian Yuan
Yangmian Yuan
MXMingrui Xiong
Mingrui Xiong
MJMuchuan Jin
Muchuan Jin
DZDonge Zhang
Donge Zhang
LZLing Zheng
Ling Zheng
Rationale: Increased methylation of key genes has been observed in kidney diseases, suggesting that the ten-eleven translocation (Tet) methyl-cytosine dioxygenase family as well as 5mC oxidation may play important roles. As a member of the Tet family, the role of Tet1 in acute kidney injury (AKI) remains unclear.

1 January 2023 in Theranostics
Verified
Journal Article
Open access
PDF file
MXMingrui Xiong
Mingrui Xiong
HCHong Chen
Hong Chen
Yu FanYu Fan
Yu Fan
MJMuchuan Jin
Muchuan Jin
DYDong Yang
Dong Yang
KHKun Huang
Kun Huang
Rationale: Ischemia-reperfusion injury (I/R) is a common cause of acute kidney injury (AKI). Post-ischemic recovery of renal blood supply plays an important role in attenuating injury. Exogenous application of elabela (ELA) peptides has been demonstrated by us and others to alleviate AKI, partly through its receptor APJ. However, the endogenous role of ELA in renal I/R remains unclear.

12 April 2023 in EMBO Reports
Verified
Journal Article
Closed access
DYDong Yang
Dong Yang
Yu FanYu Fan
Yu Fan
MXMingrui Xiong
Mingrui Xiong
YCYuchen Chen
Yuchen Chen
YZYihao Zhou
Yihao Zhou
LZLing Zheng
Ling Zheng

15 June 2021 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
YYYangmian Yuan
Yangmian Yuan
CLChengyu Liu
Chengyu Liu
XCXingrui Chen
Xingrui Chen
YSYuyan Sun
Yuyan Sun
MXMingrui Xiong
Mingrui Xiong
LZLing Zheng
Ling Zheng